Name: Antimicrobial Peptides: A Roadmap for Accelerating Discovery and Development (en Inglés)
SKU: 63359322
Price: 203.50 USD
Availability: InStock
Author: Reyes Luis H.,Cruz Juan C.,Wiedman Gregory R.
ISBN: 9780443153938

portada Antimicrobial Peptides: A Roadmap for Accelerating Discovery and Development (en Inglés)

Antimicrobial Peptides: A Roadmap for Accelerating Discovery and Development (en Inglés)

Formato

Libro Físico

Editorial

Elsevier

Autor

Reyes Luis H.,Cruz Juan C.,Wiedman Gregory R.

Idioma

Inglés

N° páginas

438

Encuadernación

Tapa Blanda

ISBN13

9780443153938

N° edición

Antimicrobial Peptides: A Roadmap for Accelerating Discovery and Development (en Inglés)

Reyes Luis H.,Cruz Juan C.,Wiedman Gregory R. (Autor) · Elsevier · Tapa Blanda

Libro Nuevo Importado

Envío: 23 a 31 días háb.

$ 370.00$ 203.50

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 203.50

Llega entre el 16 Sep y el 30 Sep a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Antimicrobial Peptides: A Roadmap for Accelerating Discovery and Development (en Inglés)"

Antimicrobial Peptides: A Roadmap for Accelerating Discovery and Development covers the most important efforts of scientists and engineers worldwide to accelerate the process of discovery, production, and eventual market penetration of more potent antimicrobial peptides. These efforts have been fueled by emerging technologies such as artificial intelligence and data science, molecular and CFD simulations, easy-to-use process simulation packages, microfluidics, 3D-printing, among many others. Such technologies can now be implemented and scaled up quickly and at relatively low cost in low-budget production facilities, critical to moving to sustainable and marketable products worldwide. Discovering novel antimicrobial peptides rationally and cost-effectively has emerged as one of the significant challenges of modern biotechnology. Thus far, this process has been tedious and costly, resulting in molecules with activities far below those needed to address the current challenge of microbial resistance to antibiotics that takes the lives of thousands of people around the world every year. Finally, the book also highlights how multidisciplinary teams have assembled to address the challenges of manufacturing, biological testing, and clinical trials to finally reach complete translation.